NOVEL POLYMERIZED CRYSTALLINE COLLOIDAL ARRAY SENSORS

Abstract: Novel sensor devices composed of a crystalline colloidal array (CCA) polymerized in a hydrogel are disclosed. The hydrogels are characterized as being capable of shrinking and swelling in response to specific stimuli applied thereto. As the hydrogels shrink or swell, the lattice structure of the CCA embedded therein changes, thereby changing the wavelength of light diffracted by the CCA. Thus by monitoring the change in diffracted wavelength, the concentration of a stimulus is determined. The gels can be modified to sense numerous different stimuli. The sensor devices are specific in that they are modified to react with only one species or family of species. These sensors have various applications in areas including, for example, environmental and chemical systems, chemomechanical systems, sensor devices and medical diagnostic tools. Various methods for making and using these devices are also disclosed.

Description: NOVEL POLYMERIZED CRYSTALLINE COLLOIDAL ARRAY SENSORS This work was supported by Office of Naval Research Grant No. N0O014-94- 1-0592; the government has certain rights in this invention. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention generally relates to optical, gel-based devices that utilize the diffraction properties of crystalline colloidal arrays. More specifically, the present invention relates to polymerized crystalline colloidal array detectors whose diffraction wavelengths change in response to a variety of specific stimuli. These detectors have application in numerous chemical, environmental and medical technologies. 2. Background Art Charged colloidal particles, when suspended in water, form a stable, crystalline dispersion due to interparticle coulomb repulsion forces. The property of structural ordering in such dispersions has been exploited in making devices such as narrow band optical rejection filters. The ordering phenomena in such colloidal suspensions have been useful in spectroscopy and Bragg diffraction techniques. It has been found that mesoscopic, crystalline structures can have many practical applications as optical filters in military, space, medical and research uses. In many such instances, it is necessary or desirable to filter narrow bands of selected wavelengths from a broader spectrum of incident radiation. Crystalline structures, or crystalline colloidal arrays (CCA), and their use in optical filtering devices are disclosed, for example, in U.S. Patent Nos. 4,627,689 and 4,632,517. Similar devices, in " which a CCA is embedded in a polymer matrix, have also been disclosed. For example, U.S. Patent Nos. 5,368,781 and 5,266,238 disclose tunable, narrow band radiation filters comprising a crystalline colloidal array of charged particles fixed in a hydrogel film. Methods for filtering incident radiation using these filters are also disclosed. U.S. Patent Nos. 5,330,685, 5,338,492 and 5,342,552 discuss narrow band radiation filters comprising a CCA of charged particles in a polymeric hydrogel. U.S. Patent No. 5,281 ,370 also discloses a method of making a solid radiation filter material including one embodiment in which the particles in the array are fused together by polymerization. Various sensor devices are also reported in the art. Schalkhammer, et al. , disclose an optical sensor that utilizes the concept of pH-dependent swelling of special polymers. See Schalkhammer, et al. , "The Use of Metal-island-coated pH Sensitive Swelling Polymers for Biosensor Applications", Sensors and Actuators B, Vol. 24-25, pp. 166-172 (1995). Conductimetric sensor devices have been proposed based on the selective swelling of hydrogels in response to pH by Sheppard, "Design of a Conductimetric Microsensor Based on Reversibly Swelling Polymer Hydrogels", Transducers '91, 173-176 (1991) and Sheppard, et al., "Microfabricated Conductimetric pH Sensor", Sensors and Actuators B, Vol. 28, pp. 95-102 (1995). Finally, sensor devices based on the selective swelling of hydrogels in response to glucose have been proposed by McCurley, "An Optical Biosensor Using A Fluorescent, Swelling Sensing Element", Biosensors and Bioelectronics, Vol. 9, pp. 527-533 (1994) and Kikuchi, et al. , "Glucose-Sensing Electrode Coated With Polymer Complex Gel Containing Phenylboronic Acid", Anal. Chem. , Vol. 68, pp. 823-828 (1996). None of the art, however, discloses a sensor device that utilizes crystalline colloidal array diffraction as a detection means, as disclosed herein. SUMMARY OF THE INVENTION The present invention is generally directed to devices comprising a hydrogel that undergoes a volume change in response to a specific chemical species, and a crystalline colloidal array (CCA) polymerized within said hydrogel. Because the volume of the hydrogel changes, the lattice spacing of the CCA embedded therein changes as well. The light diffraction properties of the CCA change as the lattice spacing is changed. Measuring the change in diffraction, therefore, indicates the presence or absence of the stimuli that causes the volume of the hydrogel to change. The present invention is also directed to methods for making and using these devices. The devices of the present invention can be used to detect a number of specific stimuli. For example, they can be used to detect the presence of various chemicals, such as metal ions in solution and organic molecules such as glucose, making the devices useful for chemical analysis. The devices can also be used to detect the presence of various gasses in solution. As a biomedical detection device, these sensors can be used to detect the presence of antigens from various sources, antibodies from various sources, and viruses such as HIV. These devices can be further used as "sense and dispense" mechanisms which detect the presence of a particular stimulus and, in response to that stimulus, release a drug or other therapeutic agent. Since none of these devices is incompatible with living cells, their use both in vitro and in vivo is contemplated. One skilled in the art will appreciate that the various embodiments disclosed herein, as well as other embodiments within the scope of the invention, will have numerous applications in the environmental, medical, pharmaceutical, metallurgy and chemical fields. It is an object of the present invention to provide a sensor device comprising a CCA polymerized in a hydrogel that changes volume in response to stimuli. It is a further object of the invention to provide a sensor device that utilizes the light diffraction properties of a CCA to detect the presence of various stimuli. A further object of the present invention is to provide a sensor device that swells in response to various stimuli, thereby changing the diffraction properties of the sensor. Another object of the invention is to provide a sensor device for detecting the presence of chemicals. Another object of the invention is to provide a sensor device for detecting the presence of gasses in solution. Another object of the invention is to provide a sensor device for detecting the presence of various medical conditions. Another object of the invention is to provide a sensor device for detecting the presence of biological molecules. It is another object of the present invention is to provide a sensor device useful in environmental applications. Another object of the present invention is to provide a sensor device having application in the field of medical diagnostics. A further object of the present invention is to provide a sensor device useful for dispensing therapeutic agents in vivo in response to the presence of stimuli. These and other objects of the invention will be more fully understood from the following description of the invention. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is an illustration of the monomers used in a hydrogel according to one embodiment of the present invention. Figure 2 demonstrates the diffraction wavelength dependence of a sensor device of the present invention on KCl concentration, as determined by the methods of Example 2. Figure 3 illustrates the response of a PCCA in KCl concentrations ranging between 0 and 100 mM as determined by the methods of Example 2. Figure 4 shows diffraction wavelength shifts of one embodiment of the present invention in response to various cations, as determined according to the methods of Example 3. Figure 5 shows the diffraction of a PCCA in response to various lead concentrations, as discussed in Example 4. Figure 6 shows the response of a PCCA to various concentrations of o-nitrophenyl-β-D-galactopyranoside, as determined according to the methods of Example 6. Figure 7 illustrates the response of a PCCA in various glucose concentrations, as determined by the methods of Example 7. DESCRIPTION OF THE INVENTION The sensor devices of the present invention generally comprise a hydrogel characterized by the property of undergoing a volume change in response to a specific chemical species; and a light diffracting crystalline colloidal array of charged particles polymerized in said hydrogel, said crystalline colloidal array having a lattice spacing that changes when said volume of said hydrogel changes thereby causing the light diffraction of said crystalline colloidal array to change. Thus, these devices are optical, gel based sensors that combine the light diffraction properties of crystalline colloidal arrays (CCA) with the conformational changes that various polymers undergo in response to external stimuli. Monodisperse, highly charged colloidal particles dispersed in very low ionic strength liquid media self-assemble due to electrostatic repulsion to form CCA. These ordered structures are either body-centered cubic (BCC) or face- centered cubic (FCC) arrays with lattice constants in the mesoscale range (50 -500 nanometers (nm)). Just as atomic crystals diffract x-rays meeting the Bragg condition, CCA diffract ultraviolet (UV), visible and near infrared (IR) light. CCA can be prepared as macroscopically ordered arrays from non-close packed spheres. Such arrays exhibit highly efficient Bragg diffraction; nearly all light meeting the Bragg condition is diffracted, while adjacent spectral regions not meeting the Bragg conditions will freely transmit. "Non-close packed spheres" refers to an ordering wherein the spheres are spaced by some distance from each other. The Bragg diffraction law is represented by the following formula: m λ = 2 nd sin θ where m is the order of diffraction, λ is the wavelength of incident light, n is the suspension refractive index, d is the interplanar spacing, and θ is the angle between the incident light and the crystal planes. Some polymers reversibly change conformation in response to a specific external stimulus. For example, almost all polymers undergo some reversible conformational change with changes in solvents, and some, such as poly N-isopropylacrylamide, undergo conformational changes in response to temperature changes. Solutes that interact with the side groups on the polymer backbone may also induce conformational changes; introduction of ionized groups onto the backbone of the polymer thus sensitizes the polymer conformation to changes in ionic strength. Polymers that change conformation in response to the concentration of a single, specific solute can therefore be prepared by adding to that polymer a functional group that selectively interacts with that single solute. Such polymers can be further mixed with crosslinking agents to form gels that exhibit the same response to stimuli as the polymer from which they are formed. For example, these gels will undergo volume changes at conditions when the constituent polymer chains change conformation. Volume changes between .1 and 50% , or even greater, are contemplated by the present invention. The volume response exhibited by these hydrogels allows for their broad application in areas including but not limited to chemomechanical systems, separation devices and sensor devices. The present invention is directed to a sensor device comprising: a hydrogel characterized by the property of undergoing a volume change in response to a specific chemical species; and a light diffracting crystalline colloidal array of charged particles polymerized in said hydrogel; said crystalline colloidal array having a lattice spacing that changes when said volume of said hydrogel changes, thereby causing the light diffraction of the crystalline colloidal array to change. The hydrogel in one embodiment of the present invention generally comprises a crosslinking agent, a gel component and a molecular recognition component. The crosslinking agent can be any crosslinking agent compatible with the other components of the hydrogel. Examples of suitable crosslinkers include N,N'- methylenebisacrylamide, methylenebismethacrylamide and ethyleneglycol- dimethacrylate, with N,N'methylenebisacrylamide being preferred. In addition to forming the polymer network in the CCA, the cross-linking agent as used in this step assists formation of the hydrogel and strengthens the resulting hydrogel film so that a self-supporting film results. Hydrogel films can be formed when as little as 1 part in 100 parts by weight of the monomer mixture is the cross-linking agent. Generally, increasing the amount of crosslinking agent lowers the sensitivity of the gel to the analyte being detected. Preferably, crosslinker is used in an amount between about 4 and 15% of monomer weight, more preferably about 5 % of monomer weight. The gel monomer " component of the hydrogels of the present invention can be any compound that forms a hydrogel that undergoes a volume change in response to a stimulus or stimuli. Examples of suitable gels include, but are not limited to, acrylamide gels, purified agarose gels, N-vinylpyrolidone gels and methacrylate gels. Preferred gels for use in the present invention are N- isopropylacrylamide (NIP A) and acrylamide. The phase transition properties of the hydrogel are modified by functionalizing the hydrogel with a reagent that specifically binds an analyte of interest. Thus the gel is modified so as to detect the presence of a stimulus by means of this molecular recognition component. More specifically, a monomer capable of selectively interacting with a specific solute is incorporated in the hydrogel. Typically, the more of the molecular recognition component, the more sensitive the device to the desired analyte. This relationship, however, is only observed up to a certain concentration of the molecular recognition component, after which the sensitivity of the gel decreases. Any monomer having molecular recognition capabilities for the desired solute can be used. For example, 4- acrylamidobenzo 18-crown-6 ether, which selectively binds Group I cations and preferably binds potassium ions, can be used if potassium is the analyte of interest. Other crown ethers, cyclodextrans, caloxarenes, and other chelating agents can also be used. When the analyte binds to the gel matrix, it causes a change in the hydrophilicity of the matrix, and therefore changes the swelling properties of the gel. As the hydrogel shrinks and swells, the CCA embedded in the hydrogel follows. As the CCA changes dimension, the resulting diffraction wavelength alteration reports on the array volume change. The diffraction shifts to shorter wavelengths as the gel shrinks, and to longer wavelengths as the gel swells. Measuring this alteration, therefore, allows for detection of the stimulus which caused the volume change. In addition, a third monomer component can be added to change the sensitivity of the device by making the hydrogel even more hydrophobic or hydrophilic, as desired by the needs of the user. The more hydrophobic the gel, the more it tends to stay in a collapsed or shrunken state. For example, an acrylamide, which is more hydrophilic than NIPA, can be added, or N-butylacrylamide, which is more hydrophobic than NIPA,- can be added to adjust the properties of the hydrogel. As stated above, the devices of the present invention combine CCA technology with modified hydrogels to provide devices useful, for example, as sensor devices. More specifically, a hydrogel having the characteristics described above is polymerized around a fluid CCA. Changes in the volume of the hydrogel matrix change the lattice spacing of the embedded CCA, thus changing the color of the light diffracted. These devices are well suited for sensor applications due to the unique ability to directly measure the volume change of the hydrogel by monitoring the diffraction wavelength from the CCA. In many applications, the change in color can be detected by the unaided eye. For example, less than a 5 % expansion in volume can yield a color change detectable by the unaided eye. A method for making a device according to the present invention generally comprises the steps of allowing charged particles to self assemble into a crystalline colloidal array; adding a first comonomer that is a gel monomer, a crosslinking agent, a second comonomer that is a molecular recognition monomer to a medium comprising said crystalline colloidal array and a polymerization initiator; and polymerizing the mixture to form a crystalline colloidal array embedded in a hydrogel. An alternative method for making a device according to the present invention generally comprises the steps of allowing charged particles to self assemble into a crystalline colloidal array; adding a crosslinking agent, a gel monomer, and a polymerization initiator; polymerizing the mixture to form a crystalline colloidal array embedded in a hydrogel; and adding a molecular recognition component capable of binding with the hydrogel. Any suitable particles can be used. For example, the particles used to create the CCA can be colloidal polystyrene, polymethylmethacrylate, silicon dioxide, aluminum oxide, polytetrafluoroethylene or any other suitable materials which are generally uniform in size and surface charge. Colloidal polystyrene is preferred. The particles are chosen depending upon the optimum degree of ordering and the resulting lattice spacing desired for the particular application. The particles preferably have a diameter between about 50 and 500 nanometers and may be either synthesized as discussed below or obtained commercially. Electrically charged particles that can be used- in accordance with this embodiment are commercially available from Dow Chemical or Poly sciences, Inc. Monodisperse particle colloids can be prepared by emulsion polymerization or any other means. For example, an emulsion polymer colloid can be prepared by mixing the desired monomer with a cross-linking agent, a surfactant to aid in the formation of the emulsion, a buffer to keep the pH of the solution constant and to prevent particle coagulation, and a free-radical initiator to initiate polymerization. In a preferred embodiment, the monomer is styrene, the cross- linking agent is divinylbenzene, the surfactant is sodium-di(l ,3- dimethylbutyl)sulfosuccinate, the initiator is preferably potassium persulfate and an ionic comonomer is also added, preferably 1 -sodium, l-allyloxy-2-hydroxypropane sulfonate. Other suitable compounds can also be used to prepare the emulsion polymer colloid, so long as compatibility problems do not arise. The particles should then be purified by the use of centrifugation, dialysis and/or an ion exchange resin. Purification of the commercially available particles is also required. Following polymerization, the particles may be stored in an ion exchange resin, preferably in a bath of 10% by weight suspension of ion exchange resin such as analytical grade AG51X8 mixed bed resin commercially available from Bio-rad of Richmond, California. The ion exchange resin should preferably be cleaned prior to use through a suitable procedure such as that of Vanderhoff et al. in the Journal of Colloid and Interface Science, Vol. 28, pp. 336-337 (1968). The electrically charged particles are then allowed to self assemble to form a crystalline colloidal array. This assembly takes place in a suitable solvent, preferably water. To the CCA medium is then added a gel monomer, a molecular recognition monomer, a cross-linking agent and a polymerization initiator. Any suitable initiator can be used, such as a thermal initiator or a photoinitiator. Preferably, a UV photoinitiator is used. A preferred UV photoinitiator for this use is 2,2'-diethoxyacetophenone. Any cross-linking agent, gel monomer and molecular recognition monomer discussed above can be used. After formation, the mixture is then polymerized. Any means known in the art can be used to initiate polymerization, so long as the method for polymerization does not destroy or otherwise disorder the CCA. Preferably, the polymerization is accomplished by placing the mixture between two plates, preferably quartz plates separated " by a parafilm spacer, at a temperature from between about 0° to 10°C. The plates are then exposed to UV light. Exposure to the UV light effects complete polymerization after about 5 minutes. Upon completion of the polymerization, the plates are removed and a stable polymerized CCA (PCCA) results. This film can be approximately about 150 microns thick and can be made thinner based upon the needs of the user. In a preferred embodiment, the hydrogel is composed of a copolymer of NIPA and 4-acrylamidobenzo 18-crown-6 ether crosslinked with N,N'- methylenebisacrylamide. This embodiment is depicted in Figure 1. The crown ether in the hydrogel complexes with metal cations, with an affinity that depends both on the ability of the cation to fit into the cavity of the crown ether, and the charge of the ion. The NIPA gel is moderately hydrophilic. The copolymer is highly sensitive to slight changes in its hydrophilicity due the complexation of small amounts of cations. As the crown ether binds with cations, the entire copolymer becomes more hydrophilic causing the PCCA to swell and the diffraction wavelength to increase. The linear NIP A/crown ether copolymer is only moderately hydrophilic and precipitates out of solution above about 38°C. At 23 °C, however, the polymer-solvent attraction is only slightly greater than the polymer-polymer attraction in the hydrogel. The device of the preferred embodiment is particularly useful as a sensor for lead. The detector swells in lead concentrations between about 2 μM and about 10 mM. This detector functions as an easy to use, sensitive detector which is blue at lead concentrations of about 2 μM or less and green at concentrations of about 20 μM. The color change of the device can be detected by the unaided human eye at lead concentrations of approximately 15 μM, and can be detected by spectrophotometry at even lower concentrations. At concentrations higher than about 20 mM, the device shrinks and the wavelength diffracted gets smaller. In addition, the device of the preferred embodiment also selectively binds group I cations, preferably binding potassium over sodium. The PCCA swells in potassium chloride (KCl) solutions at concentrations ranging from 1 to 20 mM at 23 °C and the gel begins to contract at higher KCl concentrations. Sodium ions, which have a lower affinity for the crown ether group, have little effect on the diffraction below approximately 20 mM. The maximum diffraction wavelength shift from pure water to 100 mM sodium ions is only about 15 nm whereas the maximum diffraction wavelength shift from pure water to 20 mM potassium ions is about 100 nm. The device is sensitive to concentrations of potassium ions less than 1 mM; the diffraction wavelength of the PCCA shifts 25 nm between the pure water and 1 mM KCl, which shift can be seen by the unaided human eye. Thus, the device functions as a sensitive and easy to use detector for potassium as well as lead, with a 500 fold greater affinity for lead than potassium. Alternatively, the incorporation of other crown ethers in the hydrogel could produce a sensor that selects other cations. The selectivity of the sensor is limited by non-selective binding of the crown ether with other cations. Similarly, use of functionalized compounds other than crown ethers, such as cyclodextrans, caloxarenes or other chelating agents, can produce devices that respond to still other stimuli. The response rate of the PCCA described above as the preferred embodiment, having a thickness of about. 150 microns, is typically less than about 5 minutes. Response rate can be improved by decreasing the thickness of the PCCA. The response, rate is partially determined by the mass transport of cations into the gel, and partially determined by the kinetics of complexation. Decreasing the gel thickness and the monomer content of the gel will markedly increase the rate of analyte mass transport to the active sites on the gel, and therefore decrease response time. Response rate will also be effected by. the molecular recognition component used, as some will be more selective than others. Response rates of between about 1 and 5 minutes can be achieved with a 150 micrometer thick gel and response rates on the order of seconds can be achieved with thinner gels. The response rate is inversely proportional to the thickness of the gel. In addition, the present invention contemplates embodiments in which the gel monomer will change volume in response to temperature changes. For example, NIPA hydrogels change volume with changes in temperature. Temperature has a large effect on the diffraction of the sensor in a particular concentration of KCl. The diffraction wavelength of the sensor in 5 mM KCl is 595 nm at 23°C, but increases to 710 nm at 7°C, and decreases to 495 nm at 32°C. Thus, if using a hydrogel that is also responsive to temperature, the sensor should be maintained at a constant temperature during use. In another embodiment of the present invention, the hydrogel in which the CCA is polymerized comprises a crosslinking agent, a gel monomer and a biomolecular recognition component. This biomolecular recognition component is a biomolecule that selectively binds a specific chemical specie as part of its biological function. This component can be bound to the gel directly or by one or more linking molecules. Examples of such biomolecular recognition components include but are not limited to enzymes, antibodies, antigens, porphyrins, ferritin, or pheromone receptors. These natural recognition components can respond to simple chemical species, or to the presence of particular proteins. These sensor devices can therefore further comprise one or more linking molecules that bind the biomolecular recognition component to the gel monomer. In addition, the biomolecular recognition component can be modified by being reacted with a molecule that can be bound to the linking agent, or to the gel itself. A particularly preferred linking molecule is 5-(biotinamido)pentylamine, and a preferred molecule for reaction with the biomolecular recognition component is avidin; avidin is a protein extracted from egg whites and has four binding sites for biotin. The sensor devices of this embodiment have particular application in the area of detection of disease markers, for example in detecting the presence of HIV antibodies. The gel can be sensitive to very low concentrations of species, if the recognition element has a high binding constant. This is attributable to the fact that the PCCA recognition element concentrates the analyte within the PCCA. For example, an antigen can be added to a gel monomer to form a hydrogel that binds such things as antibodies to tuberculosis cells, cancer cells, or HIV. The antigen is chosen based on what medical condition is to be detected. Enzymes can also be attached to the gel for medical diagnostics. For example, binding glucose oxidase to the hydrogel will allow for the detection of glucose. Thus this embodiment of the present invention has application as a medical diagnostic tool. As above, the sensitivity of the sensor can be adjusted to the desired concentration by modifying the ratio of gel monomer to recognition component, the degree of crosslinking and the hydrophobicity of the gel monomer. Hydrophobicity can be adjusted as discussed above with the addition of another monomer that is either more or less hydrophobic than the gel monomer, depending on the needs of the user. These biomedical sensors have potential applications both in vitro and in vivo. When used in vivo, these devices can use a "sense and dispense" mechanisms, first by sensing or detecting the presence of a chemical, or other indicia of a medical condition, and then by releasing a therapeutic agent in response to the chemical. More specifically, the hydrogel would bind to a particular stimulus that would cause the gel to swell. This swelling would allow for release of a therapeutic agent trapped within the device when the gel is in a shrunken state. The antibody and antigen based sensors function much the same way as the chemical sensors discussed above. That is, the gel volume changes when the gel becomes bound to a chemical specie that changes the hydrophobicity of the gel. In the case of the enzyme based sensors, the enzyme changes the chemical nature of the analyte by first binding to the analyte substrate and then cleaving or otherwise reacting with the analyte substrate. The gel of the enzyme based sensors swells because the interior of the gel has a high concentration of reaction products and a low concentration of analyte substrate, while the liquid surrounding the gel has the opposite characteristics. This causes an osmotic pressure imbalance between the inside and outside of the gel. A solvent, preferably water, diffuses into the gel to relieve that pressure imbalance; it is this excess solvent that causes the gel to swell. If immersed in a fresh solution of the substrate, the sensor will expand again. The response of the sensor, therefore, is dependent upon the concentration and amount of substrate in its immediate environment. The biomedical devices are made by polymerizing a CCA in a hydrogel comprising a crosslinking agent and a gel monomer such as those described above. Following formation of the PCCA, a molecular recognition component is added. In the preferred embodiment, addition of the molecular recognition component is accomplished by first hydrolyzing the PCCA. Any means known in the art can be used to effect hydrolysis; a preferred method is to place the PCCA in a 0.1 M solution of sodium hydroxide for about 10 minutes. Hydrolysis of the PCCA serves to establish acidic, reactive sites on the PCCA matrix. Preferably, the hydrolysis is a partial hydrolysis in which 10 to 30% of the reactive sites on the PCCA matrix have been acidified. This is accomplished by hydrolyzing for about 10 minutes. The acidified PCCA is then reacted with a linking molecule and a coupling agent that binds the compound in place of the acid groups on the matrix. A preferred linking molecule is a 5-(biotinamido)pentylamine and a preferred coupling agent is l-(3-dimethylaminopropyl)-3-ethylcarbodiimide. Other compounds and water soluble coupling agents can also be used. As will be appreciated by one skilled in the art, the reaction can be performed without a coupling agent, but would proceed more slowly if one is not used. The PCCA should be reacted with the linking molecule for a period of time sufficient to effect reaction of all of the acid; when using a coupling agent this is typically between about 3 to 6 hours. A molecular recognition component, such as an enzyme, antibody or antigen, is then added, and binds to the compound. The molecular recognition component is first bound to a compound having an affinity for the linking molecule. A preferred compound for this use is avidin, which is preferred when using biotin as the linking molecule. Thus the enzyme is bound to the PCCA without destroying the CCA structure or the reactivity of the enzyme. The enzymes then react with a specific compound. For example, if glucose oxidase is used as the enzyme, the gel will cleave glucose, and if /3-D-galactosidase is used as the enzyme the gel will cleave β-D-galactose. As will be appreciated by those skilled in the art, the biomolecular recognition component can be added in numerous ways. In the preferred embodiment described above, this addition is effected by reacting the biomolecular recognition component with avidin, which binds to the 5-(biotinamido)pentylamino bound to the gel matrix. This method, therefore, essentially uses two linking molecules. Embodiments using only one linking molecule or more than two linking molecule, or use of no linking molecule at all, are also within the scope of the invention. One application of the devices of the present invention is as an implant that would be placed directly under the skin. The device would detect a specific chemical stimulus in the body and undergo a volume change in response thereto. As a result of the volume change, the lattice structure of the CCA, and therefore the diffracted wavelength of the CCA, would also change. This color change could be detected through the skin. Alternatively, a device diffracted in the infrared range could be placed more deeply under the skin, such that the color change would not be visible unless an IR light source and a spectrometer was used. Another application for the devices of the present invention is to determine the concentration of a particular analyte as present in tear fluid. In this embodiment, the device would be similar to a contact lens, but would contain a sensor for determining the concentration of various analytes in the tear fluid, for example the glucose level in the tear fluid. The device would change color as the analyte concentration changed. Such devices are preferably incorporated at or near the rim of the lens, so as not to interfere with the vision of the user. In another embodiment of the present invention, the PCCA gels as discussed above are used to fabricate novel optrode sensors. In this embodiment, the PCCA is attached to the end of a fiber optic; light channelled down the fiber will be diffracted back into the fiber to carry information on the PCCA volume, and thus the analyte concentration. This embodiment is very sensitive, since a spectrometer can be used to detect very small changes in diffracted wavelength. In addition, a very fast response speed in observed. Such an optrode can be easily miniaturized since only a small piece, approximately 1 μm 3 or smaller, of the PCCA is needed for the sensor. For example, a small optrode, such as one that is as small as a few microns in thickness, can be inserted into small analyte solution volumes, into small pieces of tissue, or into a living person for clinical chemical measurements. The sensor could be modified to detect for various stimuli, such as salts, hormones, nucleic acids, amino acids, proteins or other biological species in areas as small as a single cell. In addition, by attaching a plurality of these optrode fibers and sensor arrays for different species along the slit of a spectrograph attached to a CCD camera, hundreds of different analyte concentrations can be simultaneously determined through the parallel detection of the diffracted wavelengths from these plurality of optrodes. Each of the optrodes could be attached to a different sensor with each sensor detecting a different specie, or a different concentration range of a specific specie. These optrode fibers could be designed to work by channelling light down the fiber, which will be diffracted back to a spectrometer to carry information on the PCCA volume. In yet another embodiment of the present invention, interpenetrating networks (IPNs) can be used to produce sensors with recognition elements that are normally incompatible with the required self assembly of the CCA prior to polymerization into a PCCA. For example, some molecular recognition functionalized comonomers may be ionic, and would screen the electrostatic colloidal particle repulsive interactions required for CCA self assembly. In this case, the sensor is made in two steps. First, a loosely crosslinked PCCA is formed without the molecular recognition element. Following formation of this PCCA, the functionalized monomer having the recognition element is diffused into the existing PCCA network. A second polymerization is then effected, wherein the polymer chains of the second network will form an interpenetrating network within the voids of the first network. The second network of the IPN will shrink or swell in response to the presence of the analyte, and the PCCA will expand or contract along with the second network due to the physical entanglement of the two networks. Methods of using the above devices for detecting the concentration of a selected chemical specie are also provided. Following polymerization of the CCA in the hydrogel, these methods of use further include the steps of measuring the diffracted wavelength of said crystalline colloidal array polymerized in said hydrogel; contacting said polymerized crystalline colloidal array with said solution; measuring the diffracted wavelength of said crystalline colloidal array following exposure to said solution; and comparing the change in diffracted wavelength to determine concentration of said chemical specie. As discussed above, when a stimulus, such as a chemical specie, becomes bound to said hydrogel thereby causing the volume of the hydrogel to change, the lattice spacing of the CCA also changes. Accordingly, the diffracted wavelength of the CCA changes as the volume of the hydrogel changes. By determining the change in diffracted wavelength, the volume change of the hydrogel, and therefore the concentration of the chemical specie, can be determined. The higher the concentration of the chemical specie, the greater the swelling volume of the gel. The change in diffracted wavelength can be determined by using instrumentation, such as a spectrometer or a spec trophoto meter. In many cases, the diffracted wavelength change can also be seen by the unassisted human eye because the device will change color. EXAMPLES The following examples are intended to illustrate the invention and should not be construed as limiting the invention in any way. Example 1 Charged polystyrene particles were formed by placing approximately 50 g of polystyrene and about 4 g of 1 -sodium, l-allyloxy-2-hydroxypropane sulfonate into about 100 g of water. About 4 g of sodium-di(l,3- dimethylbutyl)sulfosuccinate, about .1 g of buffer and about .5 g of sodium persulfate dissolved in about 3 ml of water were also added. The mixture was reacted for about 3.5 hours in a flask equipped with a stirring mechanism set at about 355 φm. The particles were about 105 nm in diameter and were purified by dialysis and ion exchange. A portion of the colloid suspension was removed and further dialysized for about one week in deionized water. The solution was then diluted about three- fold, and further purified by shaking with ion exchange resin until all of the impurity ions were removed and the CCA self assembled. A PCCA was then made by adding to 3 ml of the CCA medium to a mixture comprised of about 0.15 g NIPA, about 0.07 g of 4-acrylamidobenzo 18- crown-6 ether, about 0.014 g of N,N'-methylenebisacrylamide and about 0.01 g of diethoxyacetophenone. The CCA was allowed to self assemble and the CCA/gel mixture was placed between two quartz plates. The plates were then exposed to UV light for about 5 minutes. The temperature was maintained at about 5°C throughout. Example 2 The PCCA sensor made according to Example 1 was tested in potassium chloride (KCl) concentrations ranging from 1 mM to 20 mM at 23 °C. As the crown ether complexed potassium cations, the gel volume increased. The response to KCl was non-linear as can be seen from the extinction spectra of the PCCA sensor in KCl solutions of varying concentration, as is illustrated in Figure 2. At KCl concentrations above 20 mM, the PCCA began to shrink, as is shown in Figure 3. The sensor returned tσ its original diffraction color when removed from the KCl solution and immersed in a deionized water bath for 30 minutes. The response was also found to be reproducible; the diffraction peak centers of the PCCA in 5 mM KCl differed by no more than 1 nm after successive washings and re-immersion in 5 mM KCl at a constant temperature of 23°C. Example 3 The affinity of the PCCA described in Example 1 for both potassium and sodium was studied. Although the binding constants of 18-crown-6 type cyclic ethers are highest for potassium, these crown ethers still complex other cations. The maximum diffraction wavelength shift of the sensor in the presence of NaCl was 27 nm, which occurred at 100 mM NaCl. The sensitivity to NaCl is significantly lower than the response to KCl, which induced a 100 nm shift at 20 mM KCl. Calcium, although slightly smaller than sodium, caused a diffraction wavelength red shift of only 25 nm at 200 mM. The maximum response of the sensor to NaCl and CaCl 2 occurred at much higher concentrations than the maximum response to KCl. The diffraction wavelength shift of the sensor in KCl, NaCl and CaCl 2 solutions is depicted in Figure 4. This example illustrated that sodium ions do compete with potassium ions for crown ether binding sites. In 5 mM of KCl, the diffraction wavelength shifted by 90 nm from the diffraction wavelength in pure water. When immersed in a solution of 5 mM NaCl and 5 mM KCl (10 mM total salt), the diffraction wavelength shifted from the value in water by 75 nm. When the 5 mM KCl solution also contained 100 mM NaCl, the diffraction shift was only 55 nm. The diffraction wavelength in the 100 mM NaCl/5 mM KCl solution indicates a KCl concentration of approximately 1.3 mM, based on the calibration curve shown in Figure 4. Example 4 The response of the PCCA described in Example 1 to very low concentrations of lead II acetate was determined. The sensor had a response, detectable in the spectrometer, of a 10 nm shift in response to a 2 μM (approximately 410 ppb) concentration of lead II acetate. The response of 28 nm to 20 μM (about 4.1 ppm) lead II acetate is easily detectable with the unaided human eye. The device is blue at lead concentrations of 2μM and green at lead concentrations of 20 μM. The lead response reached a maximum between 10 and 20 mM; the diffraction in 20 mM lead acetate is at a lower wavelength than the diffraction in 10 mM of lead to acetate. The shift in the PCCAs diffraction due the entire detectable concentration range of lead is shown in Figure 5. The sensor returned to its original diffraction color when removed from the lead II acetate solution and immersed in a deionized water bath for 30 minutes. Due to the electrostatic character of the crown ether and cation interaction, this PCCA was found to be about 500 times more effective as a sensor for lead ions than for potassium ions. This device, therefore, functions as a lead detector. Example 5 A sensing device was made by taking a blue diffracting suspension of polystyrene colloids prepared as described above in Example 1 and polymerizing a CCA of these colloids in an acrylamide gel. The PCCA was then immersed in a 0. 1 M sodium hydroxide bath for about 10 minutes, which hydrolyzed some, but not all, of the CONH 2 groups to COOH. The hydrolyzed gel was washed in pure water to remove the sodium hydroxide. At this point, the hydrolyzed gel was swollen and diffracted in the red or infrared region. About 50 mg of 5-(biotinamido)pentylamine and about 100 mg of l-(3-dimethylaminopropyl)-3-ethyl carbodiimide were dissolved in about 1.5 ml of water. The PCCA was immersed in this solution for about 8 hours. Following this period, the reaction products were washed out of the biotinylated gel with distilled water. The spectrum of the PCCA was measured to ensure that the diffraction wavelength was at or near the original blue. About 1 mg of an avidin labelled enzyme was then dissolved in about 1 ml of water; the biotinylated gel was immersed in this solution for between about 3 and 6 hours. Example 6 The sensor device made according to Example 5, using β-D- galactosidase as the enzyme, was tested in various solutions of o-nitrophenyl-/3-D- galactopyranoside ranging from 0.10 mM to 0.33 mM; water and sucrose were used as controls. As can be seen in Figure 6, the wavelength diffracted in the water control was about 505 nm, in a .1 mM o-nitrophenyl-β-D-galactopyranoside solution was about 515 nm, in a 0.25 mM solution was about 525 and in a 0.33 mM solution was about 550; the change from 505 nm to 550 nm corresponds with a color shift from green to yellowish green at normal incidence. Diffracted wavelength was determined using a Perkin Elmer Lambda-9 spectrometer. These wavelength shifts demonstrate that the sensor devices of the present invention can be used to detect even small increases in sugar concentration. The sensor gave no response in either 0.1 or 0.2 mM of sucrose, thereby confirming that the enzyme specific reaction between o-nitrophenyl-β-D-galactopyranoside and β-D- galactosidase was causing the sensor response. Example 7 The sensor device made according to Example 5, using glucose oxidase as the enzyme, was tested for reaction with various glucose-containing solutions. As can be seen in Figure 7, the diffraction wavelength when the device was in water was approximately 550 nm. The diffracted wavelength, as measured by a Perkin Elmer Lambda-9 spectrometer, shifted to about 600 nm in a solution of 0.1 mM glucose, and to about 650 in the 0.2 mM through 0.5 mM solutions of glucose. Cleavage of the glucose by the glucose oxidase, when concentrations were at least 0.2 mM glucose, caused a wavelength shift of almost 100 nm, which corresponds to a color shift from yellowish green to deep red at normal incidence and was easily seen with the unaided human eye. Whereas particular embodiments of this invention have been described above for purposes of illustration, it will be evident to those skilled in the art that numerous variations of the details of the present invention may be made without departing from the invention as defined in the appended claims.

Claims: WHAT IS CLAIMED IS: 1. A sensor device comprising: a hydrogel that undergoes a volume change in response to a specific chemical species; and a light diffracting crystalline colloidal array of charged particles polymerized in said hydrogel; said crystalline colloidal array having a lattice spacing that changes when said volume of said hydrogel changes, thereby causing the diffracted wavelength of the crystalline colloidal array to change. 2. The sensor device of Claim' 1, wherein said hydrogel is comprised of a first comonomer that is a gel monomer, a crosslinking agent and a second comonomer that is a molecular recognition monomer. 3. The sensor device of Claim 2, wherein said device detects a particular chemical species by using as the second comonomer a monomer capable of recognizing the chemical species to be detected. 4. The sensor device of Claim 2, wherein said hydrogel is hydrophilic. The sensor device of Claim 2, wherein said gel monomer is ion-free. 6. The sensor device of Claim 5, wherein said gel monomer is selected from the group consisting of acrylamide gels, purified agarose gels, N- vinylpyrolidone gels, and methacrylate gels. 7. The sensor device of Claim 6, wherein said gel monomer is N-isopropylacrylamide. 8. The sensor device of Claim 1 , wherein said volume change is between about .1 and 50% . 9. The sensor device of Claim 1 , wherein said molecular recognition monomer is selected from the group consisting of crown ethers, cyclodextrans and caloxarenes. 10. The sensor device of Claim 9, wherein said monomer capable of molecular recognition is 4-acrylamidobenzo 18-crown-6 ether. 11. The sensor device of Claim 1 , wherein said crosslinking agent is selected from the group consisting of N,N'-methylenebisacrylamide, methylenebismethacrylamide and ethyleneglycol-dimethacrylate. 12. The sensor device of Claim 11 , wherein said crosslinking agent is N,N'-methylenebisacrylamide. 13. The sensor device of Claim 1 , wherein said charged particles are selected from the group consisting of colloidal polystyrene, poly methylmethacry late, silicon dioxide, aluminum oxide, polytetrafluoroethylene and poly N-isopropylacrylamide. 14. The sensor device of Claim 1 , wherein said stimulus is a chemical stimulus. 15. The sensor device of Claim 14, wherein said chemical stimulus is selected from the group consisting of lead ions, potassium ions and sodium ions. 16. The sensor device of Claim 2, wherein said hydrogel further comprises a third monomer. 17. The sensor device of Claim 16, wherein said third monomer is an acrylamide or a substituted acrylamide. 18. The sensor device of Claim 1 , wherein said hydrogel is comprised of a crosslinking agent, a gel monomer, and a biomolecular recognition component. 19. The sensor device of Claim 18, wherein said biomolecular recognition component is selected from the group consisting of enzymes, antigens, nucleic acids, nucleic acid sequences, amino acids, amino acid sequences, peptides and antibodies. 20. The sensor device of Claim 18, further comprising one or more linking molecules that link said biomolecular recognition component to said gel monomer. 21. The sensor device of Claim 20, wherein said linking molecule is 5-(biotinamido)pentylamine. 22. The sensor device of Claim 20, wherein said biomolecular recognition component has been reacted with a linking molecule that can be bound to a second linking molecule or to the gel. 23. The device of Claim 22, wherein avidin is the linking molecule that can be bound to a second linking agent or to the gel. 24. A method of making a sensor device comprising: a) allowing charged colloidal particles to self-assemble into a crystalline colloidal array; b) adding a first comonomer that is a gel monomer, a crosslinking agent, a second comonomer capable of molecular recognition and a polymerization initiator to a medium comprising said crystalline colloidal array; and c) polymerizing the mixture of step b) to form a crystalline colloidal array embedded in a hydrogel, wherein said hydrogel undergoes a volume change in response to a chemical species. 25. The method of Claim 24, including employing the device to detect a particular chemical species by using as the second comonomer a monomer capable of recognizing the chemical species to be detected. 26. The method of Claim 25, including employing a UV photoinitiator and wherein said polymerization step is effected by exposing the mixture of step b) to UV light. 27. The method of Claim 24, including employing a medium that is hydrophilic. 28. The method of Claim 24, including employing a gel monomer that is an ion-free gel. 29. The method of Claim 28, including employing a gel monomer selected from the group consisting of acrylamide gels, purified agarose gels, N- vinylpyrolidone gels, and methacrylate gels. 30. The method of Claim 29, including employing as said gel monomer N-isopropylacrylamide. 31. The method of Claim 24, including employing a molecular recognition monomer selected from the group consisting of crown ethers, cyclodextrans, and caloxarenes. 32. The method of Claim 31 , including employing a 4- acrylamidobenzo 18-crown-6 ether. 33. The method of Claim 24, including employing a crosslinking agent selected from the group consisting of N,N'-methylenebisacrylamide, methylenebismethacrylamide and ethyleneglycol-dimethacrylate. 34. The method of Claim 33, including employing as said crosslinking agent N,N'-methylenebisacrylamide. 35. The method of Claim 24, including employing charged particles selected from the group consisting of colloidal polystyrene, polymethylmethacrylate, silicon dioxide, aluminum oxide, polytetrafluoroethylene and poly (N-isopropylacrylamide). 36. The method of Claim 24, including employing in said hydrogel a third monomer. 37. The method of Claim 33, including employing as said third monomer an acrylamide or a substituted acrylamide. 38. A method of making a sensor device comprising: a) allowing charged colloidal particles to self assemble into a crystalline colloidal array; b) adding a gel monomer, a crosslinking agent and a polymerization initiator to a medium comprising said crystalline colloidal array; c) polymerizing the mixture of step b) to form a crystalline colloidal array embedded in a hydrogel; and d) adding a biomolecular recognition component to the product of step c), wherein said hydrogel undergoes a volume change in response to a chemical species. 39. The method of Claim 38, including employing said sensor device to detect a particular chemical species by using a biomolecular recognition component capable of recognizing the chemical species to be detected. 40. The method of Claim 38, wherein said biomolecular recognition component is added to the product of step c) by use of one or more linking molecules. 41. The method of Claim 40, wherein said biomolecular recognition component is reacted with a linking molecule that can be bound to either a second linking molecule or to the gel. 42. The method of Claim 38, including the step of hydrolyzing the polymerized crystalline colloidal array of step c) before adding a biomolecular recognition component. 43. The method of Claim 38, including employing a UV photoinitiator and wherein said polymerization step is effected by exposing the mixture of step b) to UV light. 44. The method of Claim 38, including employing a gel monomer selected from the group consisting of acrylamide gels, purified agarose gels, N- vinylpyrolidone gels, and methacrylate gels. 45. The method of Claim 44, including employing as said gel monomer N-isopropylacrylamide. 46. The method of Claim 38, including employing a biomolecular recognition component selected from the group consisting of enzymes, antigens, nucleic acids, nucleic acid sequences, amino acids, amino acid sequences, peptides and antibodies. 47. The method of Claim 38, including employing a crosslinking agent selected from the group consisting of N,N'-methylenebisacrylamide, methylenebismethacrylamide and ethyleneglycol-dimethacrylate. 48. The method of Claim 47, including employing as said crosslinking agent N,N'-methylenebisacrylamide. 49. The method of Claim 38, including employing charged particles selected from the group consisting of colloidal polystyrene, polymethylmethacrylate, silicon dioxide, aluminum oxide, polytetrafluoroethylene and poly N-isopropylacrylamide. 50. The method of Claim 40, including employing as said linking molecule 5-(biotinamido)pentylamine. 51. The method of Claim 41 , including employing avidin as the linking molecule that can be bound to a second linking agent or to the gel. 52. A method of detecting the concentration of a selected chemical species in a solution comprising: preparing a sensor device comprising a crystalline colloidal array polymerized in a hydrogel that undergoes a volume change in response to a specific chemical species, said crystalline colloidal array having a lattice spacing that changes when said volume of said hydrogel changes, thereby causing the diffracted wavelength of the crystalline colloidal array to change; measuring the diffracted wavelength of said crystalline colloidal array polymerized in said hydrogel; contacting said polymerized crystalline colloidal array with said solution; measuring the diffracted wavelength of said crystalline colloidal array following exposure to said solution; and comparing the change in diffracted wavelength measurements to determine the concentration of said chemical species. 53. The method of Claim 52, wherein the presence of said chemical species is determined by inspection of the diffracted wavelength by the polymerized crystalline colloidal array both before and after exposure to said solution, wherein a change in the wavelength diffracted by said array indicates the presence of the chemical species. 54. The method of Claim 53, including employing the use of a detection device selected from the group consisting of a spectrometer or a spectrophotometer to determine said diffracted wavelength change. 55. The method of Claim 53, including employing the unassisted human eye to determine said diffracted wavelength change, wherein such a change is detectable by a change in color of the sensor device. 56. The method of Claim 52, wherein said sensor device preparation step includes the steps of: a) allowing charged colloidal particles to self-assemble into a crystalline colloidal array; b) adding a first comonomer that is a gel monomer, a crosslinking agent, a second comonomer capable of molecular recognition and a polymerization initiator to a medium comprising said crystalline colloidal array; and c) polymerizing the mixture of step b) to form a crystalline colloidal array embedded in a hydrogel. 57. The method of Claim 56, including employing a medium that is hydrophilic. 58. The method of Claim 56, including employing a gel monomer that is an ion-free gel. 59. The method of Claim 56, including employing a gel monomer selected from the group consisting of acrylamide gels, purified agarose gels, N- vinylpyrolidone gels, and methacrylate gels. 60. The method of Claim 59, including employing as said gel monomer N-isopropylacrylamide. 61. The method of Claim 56, including employing a molecular recognition monomer selected from the group consisting of crown ethers, cyclodextrans and caloxarenes. 62. The method of Claim 61, including employing a 4- acrylamidobenzo 18-crown-6 ether. 63. The method of Claim 56, including employing a crosslinking agent selected from the group consisting of N,N'-methylenebisacrylamide, methylenebismethacrylamide and ethyleneglycol-dimethacrylate. 64. The method of Claim 63, including employing as said crosslinking agent N,N'-methylenebisacrylamide. 65. The method of Claim 56, including employing charged particles selected from the group consisting of colloidal polystyrene, polymethylmethacrylate, silicon dioxide, aluminum oxide, polytetrafluoroethylene and poly N-isopropylacrylamide. 66. The method of Claim 56, including employing in said hydrogel a third monomer. 67. The method of Claim 66, including employing as said third monomer an acrylamide or a substituted acrylamide. 68. The method of Claim 52, wherein said sensor device preparation step further comprises: a) allowing charged colloidal particles to self assemble into a crystalline colloidal array; b) adding a gel monomer, a crosslinking agent and a polymerization initiator to a medium comprising said crystalline colloidal array; c) polymerizing the mixture of step b) to form a crystalline colloidal array embedded in a hydrogel; and d) adding a biomolecular recognition component to the product of step c). 69. The method of Claim 68, wherein said biomolecular recognition component is added to the product of step c) by use of one or more linking molecules. 70. The method of Claim 69, wherein said biomolecular recognition component is reacted with a linking molecule that can be bound to a second linking molecule or to the gel. 71. The method of Claim 68, including the step of hydrolyzing the polymerized crystalline colloidal array of step c) before adding a biomolecular recognition component. 72. The method of Claim 68, including employing said sensor device to detect a particular chemical species by using a biomolecular recognition component capable of recognizing the stimulus to be detected. 73. The method of Claim 68, including employing a UV photoinitiator and wherein said polymerization step is effected by exposing the mixture of step b) to UV light. 74. The method of Claim 68, including employing a gel monomer selected from the group consisting of acrylamide gels, purified agarose gels, N- vinylpyrolidone gels, and methacrylate gels. 75. The method of Claim 74, including employing as said gel monomer N-isopropylacrylamide. 76. The method of Claim 68, including employing a biomolecular recognition component selected from the group consisting of enzymes, antigens, nucleic acids, nucleic acid sequences, amino acids, amino acid sequences, peptides and antibodies. 77. The method of Claim 68, including employing a crosslinking agent selected from the group consisting of N,N'-methylenebisacrylamide, methylenebismethacrylamide and ethyleneglycol-dimethacrylate. 78. The method of Claim 77, including employing as said crosslinking agent N,N'-methylenebisacrylamide. 79. The method of Claim 68, including employing charged particles selected from the group consisting of colloidal polystyrene, polymethylmethacrylate, silicon dioxide, aluminum oxide, polytetrafluoroethylene and poly N-isopropylacrylamide. 80. The method of Claim 69, including employing as said linking molecule 5-(biotinamido)pentylamine. 81. The method of Claim 70, including employing avidin as the linking molecule that can be bound to the second linking molecule or to the gel. 82. An optrode comprising: a fiber optic; and a sensor device comprising a crystalline colloidal array of charged particles polymerized in a hydrogel that undergoes a volume change in response to a specific chemical species, said crystalline colloidal array having a lattice spacing that changes when said volume of said hydrogel changes, thereby causing the diffracted wavelength of the crystalline colloidal array to change, attached to said fiber optic. 83. The sensor device of Claim 82, wherein said hydrogel is comprised of a crosslinking agent, a first comonomer that is a gel monomer, and a second comonomer that is a molecular recognition monomer. 84. The sensor device of Claim 83, wherein said device detects a particular chemical species by using as the second comonomer a monomer capable of recognizing the chemical species to be detected. 85. The sensor device of Claim 83, wherein said hydrogel is hydrophilic. 86. The sensor device of Claim 83, wherein said gel monomer is ion-free. 87. The sensor device of Claim 86, wherein said gel monomer is selected from the group consisting of acrylamide gels, purified agarose gels, N- vinylpyrolidone gels, and methacrylate gels. 88. The sensor device of Claim 87, wherein said gel monomer is N-isopropylacrylamide. 89. The sensor device of Claim 82, wherein said volume change is between about .1 and 50%. 90. The sensor device of Claim 83, wherein said molecular recognition monomer is selected from the group consisting of crown ethers, cyclodextrans and caloxarenes. 91. The sensor device of Claim 90, wherein said monomer capable of molecular recognition is 4-acrylamidobenzo 18-crown-6 ether. 92. The sensor device of Claim 83, wherein said crosslinking agent is selected from the group consisting of N,N'-methylenebisacrylamide, methylenebismethacrylamide and ethyleneglycol-dimethacrylate. 93. The sensor device of Claim 92, wherein said crosslinking agent is N,N'-methylenebisacrylamide. 94. The sensor device of Claim 82, wherein said charged particles are selected from the group consisting of colloidal polystyrene, polymethylmethacrylate, silicon dioxide, aluminum oxide, polytetrafluoroethylene and poly N-isopropylacrylamide. 95. The sensor device of Claim 82, wherein said hydrogel is comprised of a crosslinking agent, a gel monomer that undergoes a volume change in response to a specific chemical species and a biomolecular recognition component. 96. The sensor device of Claim 95, further comprising one or more linking molecules that link said biomolecular recognition component to said gel monomer. 97. The sensor device of Claim 96, wherein said biomolecular recognition component has been reacted with a linking molecule that can be bound to a second linking molecule or to the gel. 98. The sensor device of Claim 95, wherein said biomolecular recognition component is selected from the group consisting of enzymes, antigens, nucleic acids, nucleic acid sequences, amino acids, amino acid sequences, peptides and antibodies. 99. The sensor " device of Claim 96, wherein said linking molecule is 5-(biotinamido)pentylamine. 100. The device of Claim 97, wherein said biomolecular recognition component is reacted with avidin. 101. A method of determining an analyte concentration comprising: a) preparing a sensor device comprising a crystalline colloidal array polymerized in a hydrogel that undergoes a volume change in response to a specific chemical species, said crystalline colloidal array having a lattice spacing that changes when said volume of said hydrogel changes, thereby causing the diffracted wavelength of the crystalline colloidal array to change; b) attaching said sensor device to a fiber optic; c) inserting said fiber optic into a biological specimen; and d) determining the concentration of said analyte based on the diffracted wavelength of the sensor device. 102. The method of Claim 101, wherein said sensor device preparation step further comprises: a) allowing charged colloidal particles to self-assemble into a crystalline colloidal array; b) adding a first comonomer that is a gel monomer, a crosslinking agent, a second comonomer capable of molecular recognition and a polymerization initiator to a medium comprising said crystalline colloidal array; and c) polymerizing the mixture of step b) to form a crystalline colloidal array embedded in a hydrogel. 103. The method of Claim 101, wherein said sensor device preparation step further comprises: a) allowing charged colloidal particles to self assemble into a crystalline colloidal array; b) adding a gel monomer, a crosslinking agent and a polymerization initiator to a medium comprising said crystalline colloidal array; c) polymerizing the mixture of step b) to form a crystalline colloidal array embedded in a hydrogel; and d) adding a biomolecular recognition component to the product of step c). 104. The method of Claim 101 , wherein said biological specimen is selected from the group consisting of an analyte solution, a piece of tissue, a urine sample and a living person. 105. The method of Claim 101 , including employing said method in vitro. 106. The method of Claim 101 , including employing said method in vivo. 107. The method of Claim 101 , including employing said method in determining the concentration of one or more biological species selected from the group consisting of salts, hormones, amino acids, nucleic acids, peptides and proteins. 108. A sensor device comprising: a first network comprising a crystalline colloidal array of charged particles polymerized in a hydrogel matrix; and a second polymer network interpenetrating with said first network comprising a molecular recognition monomer, wherein said sensor device undergoes a volume change in response to a specific chemical species, said crystalline colloidal array having a lattice spacing that changes when said volume of said hydrogel changes, thereby causing the diffracted wavelength of the crystalline colloidal array to change. 109. The sensor device of Claim 108, wherein said device detects a particular chemical species by using a second polymer in said second polymer network capable of recognizing the chemical species to be detected. 110. The sensor device of Claim 108, wherein said charged particles are selected from the group consisting of colloidal polystyrene, polymethylmethacrylate, silicon dioxide, aluminum oxide, polytetrafluoroethylene and poly N-isopropylacrylamide. 11 1. The sensor device of Claim 108, wherein said hydrogel is hydrophilic. 112. The sensor device of Claim 108, wherein said gel monomer is ion-free. 113. The sensor device of Claim 111 , wherein said gel monomer is selected from the group consisting of acrylamide gels, purified agarose gels, N- vinylpyrolidone gels, and methacrylate gels. 114. The sensor device of Claim 113, wherein said gel monomer is N-isopropylacrylamide. 115. The sensor device of Claim 108, wherein said volume changes between .1 and 50%. 116. The sensor device of Claim 108, wherein said molecular recognition monomer is selected from the group consisting of crown ethers, cyclodextrans and caloxarenes. 117. The sensor device of Claim 116, wherein said monomer capable of molecular recognition is 4-acrylamidobenzo 18-crown-6 ether. 118. A method of making a sensor device comprising: a) allowing charged particles to self assemble into a crystalline colloidal array; b) adding a first comonomer that is a gel monomer, a crosslinking agent and a polymerization initiator to said crystalline colloidal array; c) polymerizing said mixture of step b) to form a hydrogel, such that a first network comprising a crystalline colloidal array polymerized in said hydrogel is formed; d) diffusing a second comonomer having a molecular recognition monomer into said first network; and e) polymerizing the product of step d) to create a second network which is interpenetrating with said first network, wherein said sensor device undergoes a volume change in response to a specific chemical species. 119. The sensor device of Claim 118, wherein said device can be modified to detect different chemical species by using as the second comonomer a monomer capable of recognizing the chemical species to be detected. 120. The sensor device of Claim 118, wherein said hydrogel is hydrophilic. 121. The sensor device of Claim 118, wherein said gel monomer is ion-free. 122. The sensor " device of Claim 121 , wherein said gel monomer is selected from the group consisting of acrylamide gels, purified agarose gels, N- vinylpyrolidone gels, and methacrylate gels. 123. The sensor device of Claim 122, wherein said gel monomer is N-isopropylacrylamide. 124. The sensor device of Claim 118, wherein said molecular recognition monomer is capable of binding to a selected analyte. 125. The sensor device of Claim 124, wherein said molecular recognition monomer is selected from the group consisting of crown ethers, cyclodextrans and caloxarenes. 126. The sensor device of Claim 125, wherein said monomer capable of molecular recognition is 4-acrylamidobenzo 18-crown-6 ether. 127. The sensor device of Claim 118, wherein said crosslinking agent is selected from the group consisting of N,N'-methylenebisacrylamide, methylenebismethacrylamide and ethyleneglycol-dimethacrylate. 128. The sensor device of Claim 126, wherein said crosslinking agent is N,N'-methylenebisacrylamide. 129. The sensor device of Claim 118, wherein said charged particles are selected from the group consisting of colloidal polystyrene, polymethylmethacrylate, silicon dioxide, aluminum oxide, polytetrafluoroethylene and poly N-isopropylacrylamide. 130. A method of dispensing a therapeutic agent comprising: a) allowing charged particles to self assemble into a crystalline colloidal array; b) adding a crosslinking agent, a first comonomer that is a gel monomer, a second comonomer that is a molecular recognition monomer and a polymerization initiator to said crystalline colloidal array; c) polymerizing the mixture of step b) to form a hydrogel; d) embedding a therapeutic agent within said polymerized hydrogel; and e) inserting said polymerized hydrogel into a biological specimen containing a stimulus, wherein said polymerized hydrogel detects the presence of said stimulus, binds to said stimulus, swells, and releases the therapeutic agent embedded therein. 131. The method of Claim 56, including employing as said molecular recognition monomer a chelating agent capable of binding. 132. The sensor device of Claim 118, wherein said hydrogel is hydrophobic. 133. A sensor device for measuring analyte concentration in the tear fluid comprising: a hydrogel that undergoes a volume change in response to a specific chemical species; a light diffracting crystalline colloidal array of charged particles polymerized in said hydrogel, said crystalline colloidal array having a lattice spacing that changes when said volume of said hydrogel changes, thereby causing the diffracted wavelength of the crystalline colloidal array to change; and wherein said sensor device is place on the eye. 134. An implant device for determining the analyte concentration in the body comprising: a hydrogel that undergoes a volume change in response to a specific chemical species; a light diffracting crystalline colloidal array of charged particles polymerized in said hydrogel, said crystalline colloidal array having a lattice spacing that changes when said volume of said hydrogel changes, thereby causing the diffracted wavelength of the crystalline colloidal array to change; and wherein said implant device is implanted beneath the skin of the user. 135. The implant device of Claim 134, wherein said device is placed directly under the skin and said diffracted wavelength of the crystalline colloidal array can be seen through the skin. 136. The implant device of Claim 134, wherein said implant device diffracts in the infrared range and is placed under the skin of the user and wherein said diffraction of the crystalline colloidal array is determined by use of infrared spectrometry. 137. The sensor device of Claim 2, wherein said hydrogel is hydrophobic. 138. The method- of Claim 24, including employing a medium that is hydrophobic. 139. The method of Claim 56, including employing a medium that is hydrophobic. 140. The sensor device of Claim 83, wherein said hydrogel is hydrophobic. 141. The sensor device of Claim 108, wherein said hydrogel is hydrophobic.

Inventors: ASHER SANFORD A, HOLTZ JOHN H, ASHER, SANFORD, A., HOLTZ, JOHN, H.
Applicants: UNIV PITTSBURGH, UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTE
Application year: 1997
Main classification: B01J13
IPC codes: B01J13, C08F2, C08F220, G01J3, G01N21, G01N31, G02B26